What is the clinical evidence from this study?

Study design: Other. Population: Diabetic cardiomyopathy. Intervention: Fibroblast-specific ccn1 knockout vs. Control. Primary outcome: Cardiac dysfunction and autophagic activity.

What does this research mean for the field?

Fibroblast-derived CCN1 drives the progression of diabetic cardiomyopathy by suppressing cardiomyocyte autophagy via ITGAV-ITGB1/integrin αvβ1-dependent PTK2/FAK-MTOR signaling. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.ESTABLISHES_NEW_DIRECTION.

What question did this study set out to answer?

Investigate how cardiac fibroblast-derived CCN1 regulates cardiomyocyte autophagy and contributes to diabetic cardiomyopathy pathogenesis.

September 14, 2026Open Access

Fibroblast-specific ccn1 deletion ameliorates cardiac dysfunction in diabetic cardiomyopathy mice by restoring autophagic activity.

View Full Paper

Ask AI

Bookmark

Why the study?

The specific impact of fibroblast-derived CCN1 on cardiomyocyte function and diabetic cardiomyopathy progression was unclear.

Population

Diabetic cardiomyopathy mouse models and insulin-resistant cell models

Comparison

Fibroblast-specific ccn1 knockout vs wild-type mice

Design

Preclinical mechanistic study

Key result

Fibroblast-specific ccn1 deletion ameliorated cardiac dysfunction and restored autophagic activity in a diabetic cardiomyopathy mouse model.

Authors

BHBo‐ang Hu LZLei Zhang MSMing Song

Discussion

Member takes

Overview

Suggests CCN1 as a potential target in diabetic cardiomyopathy; leaves open its role in human disease and requires prospective validation.

Key Points

Investigate how cardiac fibroblast-derived CCN1 regulates cardiomyocyte autophagy and contributes to diabetic cardiomyopathy pathogenesis.
Assessed CCN1 expression across diabetic cardiomyopathy mouse models and insulin-resistant cellular assays.
Generated fibroblast-specific ccn1 knockout mice to evaluate diabetic cardiac remodeling and macroautophagy in vivo.
Performed proteomics, co-culture assays, molecular dynamics simulations, and co-immunoprecipitation to identify the interacting receptor and downstream pathway.
Elevated fibroblast-derived CCN1 bound cardiomyocyte integrin αvβ1 via its cysteine-knot-containing domain.
CCN1-integrin αvβ1 interaction activated downstream PTK2/FAK-MTOR signaling, which directly suppressed cardiomyocyte macroautophagy.
Targeted fibroblast-specific deletion of ccn1 restored autophagic flux and alleviated diabetic cardiac dysfunction in mice.

Structured PICO

Population

Diabetic cardiomyopathy mouse models, insulin-resistant cell models, and fibroblast-specific ccn1 knockout mice

Intervention

Fibroblast-specific ccn1 deletion

Comparator

Control/wild-type mice with diabetic cardiomyopathy

Outcome

Cardiac dysfunction and autophagic activitysurrogate

Fibroblast-derived CCN1 drives diabetic cardiomyopathy progression by suppressing cardiomyocyte autophagy via ITGAV-ITGB1/integrin αvβ1 signaling, identifying it as a potential therapeutic target.

Cite This Study

Hu et al. (2026) studied Diabetic cardiomyopathy. Fibroblast-specific ccn1 knockout vs. Control was evaluated on Cardiac dysfunction and autophagic activity. Fibroblast-specific ccn1 deletion ameliorated cardiac dysfunction and restored autophagic activity in a diabetic cardiomyopathy mouse model.

synapsesocial.com/papers/6aa7afef79e9260bc85aacea https://doi.org/10.1080/15548627.2026.2667721

View Full Paper

Ask AI

Bookmark

September 14, 2026Open Access

Fibroblast-specific ccn1 deletion ameliorates cardiac dysfunction in diabetic cardiomyopathy mice by restoring autophagic activity.

View Full Paper

Ask AI

Bookmark

Why the study?

The specific impact of fibroblast-derived CCN1 on cardiomyocyte function and diabetic cardiomyopathy progression was unclear.

Population

Diabetic cardiomyopathy mouse models and insulin-resistant cell models

Comparison

Fibroblast-specific ccn1 knockout vs wild-type mice

Design

Preclinical mechanistic study

Key result

Fibroblast-specific ccn1 deletion ameliorated cardiac dysfunction and restored autophagic activity in a diabetic cardiomyopathy mouse model.

Authors

BHBo‐ang Hu LZLei Zhang MSMing Song

Discussion

Member takes

Overview

Suggests CCN1 as a potential target in diabetic cardiomyopathy; leaves open its role in human disease and requires prospective validation.

Key Points

Investigate how cardiac fibroblast-derived CCN1 regulates cardiomyocyte autophagy and contributes to diabetic cardiomyopathy pathogenesis.
Assessed CCN1 expression across diabetic cardiomyopathy mouse models and insulin-resistant cellular assays.
Generated fibroblast-specific ccn1 knockout mice to evaluate diabetic cardiac remodeling and macroautophagy in vivo.
Performed proteomics, co-culture assays, molecular dynamics simulations, and co-immunoprecipitation to identify the interacting receptor and downstream pathway.
Elevated fibroblast-derived CCN1 bound cardiomyocyte integrin αvβ1 via its cysteine-knot-containing domain.
CCN1-integrin αvβ1 interaction activated downstream PTK2/FAK-MTOR signaling, which directly suppressed cardiomyocyte macroautophagy.
Targeted fibroblast-specific deletion of ccn1 restored autophagic flux and alleviated diabetic cardiac dysfunction in mice.

Structured PICO

Population

Diabetic cardiomyopathy mouse models, insulin-resistant cell models, and fibroblast-specific ccn1 knockout mice

Intervention

Fibroblast-specific ccn1 deletion

Comparator

Control/wild-type mice with diabetic cardiomyopathy

Outcome

Cardiac dysfunction and autophagic activitysurrogate

Fibroblast-derived CCN1 drives diabetic cardiomyopathy progression by suppressing cardiomyocyte autophagy via ITGAV-ITGB1/integrin αvβ1 signaling, identifying it as a potential therapeutic target.

Cite This Study

synapsesocial.com/papers/6aa7afef79e9260bc85aacea https://doi.org/10.1080/15548627.2026.2667721

View Full Paper

Ask AI

Bookmark